By www.reliableresearchiq.com
Global Specialty Generics Key Trends And Opportunities To 2031 Story
176
$ 6600
Specialty Generics Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Teva Pharmaceuticals Industries Akorn, Inc. Mylan N.V. Mallinckrodt Sandoz International GmbH Pfizer, Inc. Sun Pharmaceutical Industries Ltd. Valeant Pharmaceuticals Apotex Corp. Endo International plc.